Sign in

CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company

Ernexa Therapeutics Inc.

Sign in to watch
Ticker
ERNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
311103425
Phone
(617) 798-6700
Business address
1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
Former names
Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC

Securities

  • ERNA Common Stock Nasdaq
  • ERNAW Warrants Nasdaq
  1. 8-K Event Bylaws or fiscal year change · Other events
  2. 8-K Event Shareholder vote results
  3. 4 Option exercise Chief Medical Officer acquired 20,163 shares (option exercise)
  4. 8-K Event Material agreement
  5. 8-K/A Event Executive or director change
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 10-Q Report Quarterly Report
  9. 8-K Event Executive or director change
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. 8-K Event Executive or director change
  17. 8-K Event Delisting notice
  18. 10-Q Report Quarterly Report
  19. 10-K/A Report 10-K/A
  20. 4 Shares withheld for taxes Chief Scientific Officer gave up 6,077 shares (to pay taxes)

Page 13 of 77 · 1,525 filings